JP2024075624A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024075624A5 JP2024075624A5 JP2024037742A JP2024037742A JP2024075624A5 JP 2024075624 A5 JP2024075624 A5 JP 2024075624A5 JP 2024037742 A JP2024037742 A JP 2024037742A JP 2024037742 A JP2024037742 A JP 2024037742A JP 2024075624 A5 JP2024075624 A5 JP 2024075624A5
- Authority
- JP
- Japan
- Prior art keywords
- transcription factor
- family
- hormone receptor
- nuclear hormone
- receptor family
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862647433P | 2018-03-23 | 2018-03-23 | |
| US62/647,433 | 2018-03-23 | ||
| PCT/US2019/023637 WO2019183508A1 (en) | 2018-03-23 | 2019-03-22 | Endothelial cell factors and methods thereof |
| JP2020550792A JP7455067B2 (ja) | 2018-03-23 | 2019-03-22 | 内皮細胞因子およびその方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550792A Division JP7455067B2 (ja) | 2018-03-23 | 2019-03-22 | 内皮細胞因子およびその方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024075624A JP2024075624A (ja) | 2024-06-04 |
| JP2024075624A5 true JP2024075624A5 (https=) | 2024-08-19 |
| JP7683068B2 JP7683068B2 (ja) | 2025-05-26 |
Family
ID=67987596
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550792A Active JP7455067B2 (ja) | 2018-03-23 | 2019-03-22 | 内皮細胞因子およびその方法 |
| JP2024037742A Active JP7683068B2 (ja) | 2018-03-23 | 2024-03-12 | 内皮細胞因子およびその方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550792A Active JP7455067B2 (ja) | 2018-03-23 | 2019-03-22 | 内皮細胞因子およびその方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12146165B2 (https=) |
| EP (1) | EP3768282A4 (https=) |
| JP (2) | JP7455067B2 (https=) |
| CN (1) | CN112105721A (https=) |
| CA (1) | CA3094837A1 (https=) |
| WO (1) | WO2019183508A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025096798A2 (en) * | 2023-10-31 | 2025-05-08 | The Children's Medical Center Corporation | Endothelial cell factors and methods thereof |
| CN118834915A (zh) * | 2024-08-15 | 2024-10-25 | 扬州大学 | 一种在羊毛乳头细胞中稳定过表达的sox18慢病毒重组标签载体的构建及应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009042910A2 (en) | 2007-09-26 | 2009-04-02 | University Of South Florida | Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis |
| US20050227352A1 (en) * | 2004-04-09 | 2005-10-13 | Stowers Institute For Medical Research | Use of BMP (BAM) signaling to control stem cell fate determination |
| JP5139271B2 (ja) | 2005-05-24 | 2013-02-06 | ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ | 培養した造血幹細胞を拡大しかつ分析する方法 |
| US20120207744A1 (en) * | 2009-03-19 | 2012-08-16 | Mendlein John D | Reprogramming compositions and methods of using the same |
| US20130243736A1 (en) * | 2012-01-27 | 2013-09-19 | Sapporo Medical University | Replacement of bone marrow niche cells for treatment of various diseases |
| GB201212111D0 (en) * | 2012-07-06 | 2012-08-22 | Gmbh | Vascular bed-specific endothelial cells |
| US20140162366A1 (en) * | 2012-08-31 | 2014-06-12 | Salk Institute For Biological Studies | Generation of vascular progenitor cells |
| US9382531B2 (en) * | 2012-10-22 | 2016-07-05 | Wisconsin Alumni Research Foundation | Induction of hemogenic endothelium from pluripotent stem cells |
| JP6581906B2 (ja) * | 2013-01-15 | 2019-09-25 | コーネル ユニヴァーシティー | 確定因子によるヒト内皮の造血性多系列前駆細胞へのリプログラミング |
| KR102571649B1 (ko) * | 2014-12-19 | 2023-08-25 | 앤지오크린 바이오사이언스 인코포레이티드 | 조작된 내피 세포를 포함하는 생체적합성 임플란트 |
| EP3307873A4 (en) * | 2015-06-09 | 2018-12-05 | The Regents of The University of California | Hematopoietic cells and methods of using and generating the same |
| CN108291196B (zh) * | 2015-07-20 | 2021-08-27 | 安吉克莱茵生物科学有限公司 | 表达ets转录因子的工程化的内皮细胞 |
| EP4202036A1 (en) | 2015-07-20 | 2023-06-28 | Angiocrine Bioscience, Inc. | Methods and compositions for stem cell transplantation |
-
2019
- 2019-03-22 EP EP19772190.5A patent/EP3768282A4/en active Pending
- 2019-03-22 CN CN201980020598.1A patent/CN112105721A/zh active Pending
- 2019-03-22 US US17/040,421 patent/US12146165B2/en active Active
- 2019-03-22 CA CA3094837A patent/CA3094837A1/en active Pending
- 2019-03-22 JP JP2020550792A patent/JP7455067B2/ja active Active
- 2019-03-22 WO PCT/US2019/023637 patent/WO2019183508A1/en not_active Ceased
-
2024
- 2024-03-12 JP JP2024037742A patent/JP7683068B2/ja active Active
- 2024-09-04 US US18/824,457 patent/US20240417695A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Autologous stem cell transplantation for myocardial repair | |
| JP2024075624A5 (https=) | ||
| Minguell et al. | Biology and clinical utilization of mesenchymal progenitor cells | |
| Hou et al. | Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats | |
| JP5202953B2 (ja) | 心臓幹細胞 | |
| He et al. | The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning | |
| Cores et al. | Safety and efficacy of allogeneic lung spheroid cells in a mismatched rat model of pulmonary fibrosis | |
| Sunil et al. | Stem cell therapy in oral and maxillofacial region: An overview | |
| CN108642054A (zh) | 降低免疫原性sgRNA、低免疫原性敷料及其制备方法 | |
| CN107354127B (zh) | LncRNA-TUG1在调控PDLSCs成骨分化及组织再生中的作用 | |
| Sano et al. | Intrinsic activation of cardiosphere-derived cells enhances myocardial repair | |
| CN111500578A (zh) | 调控ADSCs成骨分化及组织再生Circ RNA-FTO及其应用 | |
| Wang et al. | Enhancement of bone formation by genetically engineered human umbilical cord–derived mesenchymal stem cells expressing osterix | |
| Lakota et al. | Human mesenchymal stem cells: the art to use them in the treatment of previously untreatable | |
| EP1405906A4 (en) | SCHWANN CELLS FROM INTERSTITIAL MYELOID CELLS | |
| KR20240028370A (ko) | 3차원 배양된 탯줄 유래 중간엽 줄기세포 및 이의 용도 | |
| Etzion et al. | Myocardial regeneration: present and future trends | |
| Chen et al. | Tissue engineering of bladder using vascular endothelial growth factor gene-modified endothelial progenitor cells | |
| Ahmad et al. | Direct differentiation of rat skin fibroblasts into cardiomyocytes | |
| Shi et al. | Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications | |
| JP4554940B2 (ja) | ヒト胎盤由来の間葉系細胞を含む医薬及び該細胞を用いたｖｅｇｆの製造方法 | |
| CN104561101B (zh) | MicroRNA 221‑3p在制备表皮细胞中的方法及应用 | |
| Fauza | Tissue engineering and transplantation in the fetus | |
| US20230383257A1 (en) | Production of megakaryocytes and platelets in a co-culture system | |
| Masoudi et al. | Immunogenicity against hepatitis C virus with mesenchymal stem cells of inbreed BALB/c mice sub cloned with HCVcp protein gene |